SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-289550
Filing Date
2023-12-06
Accepted
2023-12-06 07:30:29
Documents
19
Period of Report
2023-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d628270d8k.htm   iXBRL 8-K 50192
2 EX-4.1 d628270dex41.htm EX-4.1 94767
3 EX-10.1 d628270dex101.htm EX-10.1 239941
4 EX-99.1 d628270dex991.htm EX-99.1 32934
5 EX-99.2 d628270dex992.htm EX-99.2 9869
9 GRAPHIC g628270g12g12.jpg GRAPHIC 153018
10 GRAPHIC g628270page1.jpg GRAPHIC 7559
11 GRAPHIC g628270page1a.jpg GRAPHIC 7677
  Complete submission text file 0001193125-23-289550.txt   1077393

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA coya-20231205.xsd EX-101.SCH 2878
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20231205_lab.xml EX-101.LAB 18738
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20231205_pre.xml EX-101.PRE 11726
13 EXTRACTED XBRL INSTANCE DOCUMENT d628270d8k_htm.xml XML 3518
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 231468421
SIC: 2834 Pharmaceutical Preparations